Clinical Study

D419br00008- A Prospective, Non-Interventional Study To Assess The Prevalence Of Pd-L1 Expression In The First-Line Setting Of Locally Advanced/Unresectable Or Metastatic Urothelial Carcinoma

Posted Date: Feb 5, 2020

  • Investigator: Shuchi Gulati
  • Specialties: Cancer, Oncology
  • Type of Study: Observational/Survey

The primary goal of this study is to assess the prevalence of pre-treatment tumor tissue PD-L1 high expression in the 1L setting in advanced UC patients (locally advanced/unresectable or metastatic) using the Ventana SP263 assay.

Criteria:

Must Have Urothelial Carcinoma, Be At Least 18 Years Of Age, No Prior Systemic Therapy For Uc, No History Of Non-Urothelial Malignancy Within 2 Years,

Keywords:

Urothelial Cancer, Gu

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.